Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA5089196
Max Phase: Preclinical
Molecular Formula: C34H48F3N6O14P
Molecular Weight: 852.75
Molecule Type: Unknown
Associated Items:
ID: ALA5089196
Max Phase: Preclinical
Molecular Formula: C34H48F3N6O14P
Molecular Weight: 852.75
Molecule Type: Unknown
Associated Items:
Canonical SMILES: COC(=O)[C@H](CC(C)C)NC(=O)[C@@H]1CC[C@H]2OCCNC(=O)CC[C@H](NC(=O)c3cccc(C(F)(F)F)c3)C(=O)N[C@@H](CO)C(=O)N[C@@H]([C@@H](C)OP(=O)(O)O)C(=O)N21
Standard InChI: InChI=1S/C34H48F3N6O14P/c1-17(2)14-22(33(51)55-4)40-31(49)24-9-11-26-43(24)32(50)27(18(3)57-58(52,53)54)42-30(48)23(16-44)41-29(47)21(8-10-25(45)38-12-13-56-26)39-28(46)19-6-5-7-20(15-19)34(35,36)37/h5-7,15,17-18,21-24,26-27,44H,8-14,16H2,1-4H3,(H,38,45)(H,39,46)(H,40,49)(H,41,47)(H,42,48)(H2,52,53,54)/t18-,21+,22+,23+,24+,26-,27+/m1/s1
Standard InChI Key: AQVFEOGYDIPWJH-WVBPCUAESA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Unknown | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 852.75 | Molecular Weight (Monoisotopic): 852.2918 | AlogP: -0.79 | #Rotatable Bonds: 11 |
Polar Surface Area: 288.33 | Molecular Species: ACID | HBA: 12 | HBD: 8 |
#RO5 Violations: 3 | HBA (Lipinski): 20 | HBD (Lipinski): 8 | #RO5 Violations (Lipinski): 3 |
CX Acidic pKa: 1.34 | CX Basic pKa: | CX LogP: -1.36 | CX LogD: -4.78 |
Aromatic Rings: 1 | Heavy Atoms: 58 | QED Weighted: 0.10 | Np Likeness Score: 0.13 |
1. Ryu S, Park JE, Ham YJ, Lim DC, Kwiatkowski NP, Kim DH, Bhunia D, Kim ND, Yaffe MB, Son W, Kim N, Choi TI, Swain P, Kim CH, Lee JY, Gray NS, Lee KS, Sim T.. (2022) Novel Macrocyclic Peptidomimetics Targeting the Polo-Box Domain of Polo-Like Kinase 1., 65 (3.0): [PMID:35029981] [10.1021/acs.jmedchem.1c01359] |
Source(1):